The pharmacology of ATP-sensitive potassium channels.
暂无分享,去创建一个
[1] G. Edwards,et al. Inhibition by adrenergic neurone blocking agents of the relaxation induced by BRL 38227 in vascular, intestinal and uterine smooth muscle , 1992, British journal of pharmacology.
[2] K. Okamoto,et al. Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonists. , 1992, European journal of pharmacology.
[3] G. Edwards,et al. Characterization of potassium currents modulated by BRL 38227 in rat portal vein , 1992, British journal of pharmacology.
[4] U. Quast,et al. A specific binding site for K+ channel openers in rat aorta. , 1992, The Journal of biological chemistry.
[5] M. Lazdunski,et al. TMB-8 (8-(N,N-diethylamino) octyl-3,4,5-trimethoxybenzoate) inhibits the ATP-sensitive K+ channel. , 1992, European journal of pharmacology.
[6] U. Panten,et al. Effect of MgATP on pinacidil‐induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic β‐cell line and rat cerebral cortex , 1992, British journal of pharmacology.
[7] K. Okumura,et al. Effects of imidazoline-related compounds on the mechanical response to nicorandil in the rat portal vein. , 1992, European journal of pharmacology.
[8] D. Criddle,et al. The involvement of potassium channels in the action of ciclazindol in rat portal vein , 1992, British journal of pharmacology.
[9] D. Eckman,et al. Comparison of the actions of acetylcholine and BRL 38227 in the guinea‐pig coronary artery , 1992, British journal of pharmacology.
[10] J. Horáček,et al. Relaxant effects of BRL 38227 and pinacidil on the rat gastric fundus. , 1992, European journal of pharmacology.
[11] Y. Hattori,et al. Glibenclamide does not block arterial relaxation caused by vasoactive intestinal polypeptide. , 1992, European journal of pharmacology.
[12] L. Clapp,et al. ATP-sensitive K+ channels regulate resting potential of pulmonary arterial smooth muscle cells. , 1992, The American journal of physiology.
[13] J. Nielsen-Kudsk,et al. Smooth muscle relaxation and inhibition of responses to pinacidil and cromakalim induced by phentolamine in guinea-pig isolated trachea. , 1992, European journal of pharmacology.
[14] C. Garland,et al. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery , 1992, British journal of pharmacology.
[15] J. Huizinga,et al. Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal peptide in colonic smooth muscle. , 1992, The Journal of pharmacology and experimental therapeutics.
[16] Chris Peers,et al. Glibenclamide inhibits a voltage-gated K+ current in the human neuroblastoma cell line SH-SY5Y , 1992, Neuroscience Letters.
[17] N. Morgan,et al. The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells , 1991 .
[18] J. Henquin,et al. Clonidine inhibits ATP‐sensitive K+channels in mouse pancreatic β‐cells , 1991 .
[19] E. Daniel,et al. Nitric oxide may be the final mediator of nonadrenergic, noncholinergic inhibitory junction potentials in the gut. , 1991, Canadian journal of physiology and pharmacology.
[20] M. Welsh,et al. Characterization of the solubilized glibenclamide receptor in a hamster pancreatic beta-cell line, HIT T15. , 1991, The Biochemical journal.
[21] R. Kovacs,et al. ATP-sensitive K+ channels from aortic smooth muscle incorporated into planar lipid bilayers. , 1991, The American journal of physiology.
[22] U. Quast,et al. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim. , 1991, European journal of pharmacology.
[23] D. Atlas,et al. Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity. , 1991, Biochemical pharmacology.
[24] F. Ashcroft,et al. Separate processes mediate nucleotide-induced inhibition and stimulation of the ATP-regulated K+-channels in mouse pancreatic β-cells , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[25] Y. Ben-Ari,et al. Two binding sites for [3H]glibenclamide in the rat brain , 1991, Brain Research.
[26] D. Kunze,et al. Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell. , 1991, The Journal of biological chemistry.
[27] Z. Fan,et al. Multiple actions of pinacidil on adenosine triphosphate‐sensitive potassium channels in guinea‐pig ventricular myocytes. , 1990, The Journal of physiology.
[28] S. Silberberg,et al. An ATP, calcium and voltage sensitive potassium channel in porcine coronary artery smooth muscle cells. , 1990, Biochemical and biophysical research communications.
[29] G. Edwards,et al. Structure-activity relationships of K+ channel openers. , 1990, Trends in pharmacological sciences.
[30] J. Baeyens,et al. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. , 1990, European journal of pharmacology.
[31] P. Grafe,et al. K+ channel openers suppress myotonic activity of human in vitro , 1990 .
[32] J. Henquin,et al. Phentolamine and yohimbine inhibit ATP‐sensitive K+ channels in mouse pancreatic β‐cells , 1990, British journal of pharmacology.
[33] M. Oike,et al. Nicorandil opens a calcium-dependent potassium channel in smooth muscle cells of the rat portal vein. , 1990, The Journal of pharmacology and experimental therapeutics.
[34] J. F. Caro,et al. Effects of glyburide on carbohydrate metabolism and insulin action in the liver. , 1990, The American journal of medicine.
[35] L. Aguilar-Bryan,et al. Molecular mechanisms of action of glyburide on the beta cell. , 1990, The American journal of medicine.
[36] J B Patlak,et al. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. , 1990, The American journal of physiology.
[37] Y. Tourneur,et al. Action of cromakalim on potassium membrane conductance in isolated heart myocytes of frog , 1990, British journal of pharmacology.
[38] I. Niki,et al. The beta-cell glibenclamide receptor is an ADP-binding protein. , 1990, The Biochemical journal.
[39] O. Rorstad,et al. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. , 1990, European journal of pharmacology.
[40] J. Angus,et al. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists , 1990, British journal of pharmacology.
[41] P. Grafe,et al. Enhancement of K+ conductance improves in vitro the contraction force of skeletal muscle in hypokalemic periodic paralysis , 1990, Muscle & nerve.
[42] N. Standen,et al. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels , 1990, Nature.
[43] J. Daut,et al. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. , 1990, Science.
[44] A. Weston,et al. Actions of cromakalim on ionic currents recorded from single smooth muscle cells of the rat portal vein. , 1990, The Journal of pharmacology and experimental therapeutics.
[45] A. Gibson,et al. l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.
[46] N. Davies,et al. Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons , 1990, Nature.
[47] W. Lederer,et al. Nucleotide modulation of the activity of rat heart ATP‐sensitive K+ channels in isolated membrane patches. , 1989, The Journal of physiology.
[48] R. Kass,et al. Activation of ATP-sensitive K channels in heart cells by pinacidil: dependence on ATP. , 1989, The American journal of physiology.
[49] D. Escande,et al. Apparent competition between ATP and the potassium channel opener RP 49356 on ATP-sensitive K+ channels of cardiac myocytes. , 1989, Molecular pharmacology.
[50] R. Haworth,et al. Inhibition of ATP-Sensitive Potassium Channels of Adult Rat Heart Cells by Antiarrhythmic Drugs , 1989, Circulation research.
[51] S. Sikdar,et al. Differential modulation of Ca2+-activated K+ channels in ovine pituitary gonadotrophs by GnRH, Ca2+ and cyclic AMP , 1989, Brain Research.
[52] L. Raeymaekers,et al. Preferential support of Ca2+ uptake in smooth muscle plasma membrane vesicles by an endogenous glycolytic cascade , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] M. Rogawski,et al. BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons. , 1989, European journal of pharmacology.
[54] F. Ashcroft,et al. ATP‐sensitive K+ channels in rat pancreatic beta‐cells: modulation by ATP and Mg2+ ions. , 1989, The Journal of physiology.
[55] R. Kass,et al. Enhancement of potassium-sensitive current in heart cells by pinacidil. Evidence for modulation of the ATP-sensitive potassium channel. , 1989, Circulation research.
[56] J. Angus,et al. Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromakalim , 1989, British journal of pharmacology.
[57] Y. Ari,et al. Galanin protects hippocampal neurons from the functional effects of anoxia. , 1989, European journal of pharmacology.
[58] N. Standen,et al. Multiple blocking mechanisms of ATP‐sensitive potassium channels of frog skeletal muscle by tetraethylammonium ions. , 1989, The Journal of physiology.
[59] T. Hamilton,et al. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat , 1989, British journal of pharmacology.
[60] M. Lazdunski,et al. Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices , 1989, Brain Research.
[61] S. Lenzen,et al. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. , 1989, Biochemical pharmacology.
[62] K. Gillis,et al. Metabolite-Regulated ATP-Sensitive K+ Channel in Human Pancreatic Islet Cells , 1989, Diabetes.
[63] P. Rorsman,et al. Does galanin inhibit insulin secretion by opening of the ATP-regulated K+ channel in the β-cell? , 1989, Peptides.
[64] Johan F. Storm,et al. Temporal integration by a slowly inactivating K+ current in hippocampal neurons , 1988, Nature.
[65] O. Hutter,et al. Single‐channel activity in sarcolemmal vesicles from human and other mammalian muscles , 1988, Muscle & nerve.
[66] S. G. Taylor,et al. Endothelium-derived hyperpolarizing a new endogenous inhibitor from the vascular endothelium , 1988 .
[67] B. Ribalet,et al. Metabolic regulation of the K(ATP) and a maxi-K(V) channel in the insulin-secreting RINm5F cell , 1988, The Journal of general physiology.
[68] D. Escande,et al. The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. , 1988, Biochemical and biophysical research communications.
[69] P. Barnes,et al. Calcitonin gene‐related peptide (CGRP) is a potent non‐endothelium‐dependent inhibitor of coronary vasomotor tone , 1987, British journal of pharmacology.
[70] M. Lazdunski,et al. The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. , 1987, The Journal of biological chemistry.
[71] L. Ignarro,et al. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. , 1987, The American journal of physiology.
[72] D. Bataille,et al. A binding site for [3H]glipizide in the rat cerebral cortex. , 1987, European journal of pharmacology.
[73] M. Pfeifer,et al. α-Adrenergic Blockade Improves Glucose-Potentiated Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus , 1987, Diabetes.
[74] O. Petersen,et al. Electrophysiology of the pancreas. , 1987, Physiological reviews.
[75] F. Ashcroft,et al. ATP‐sensitive K+ channels in human isolated pancreatic B‐cells , 1987, FEBS letters.
[76] K. Magleby,et al. Single apamin-blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscle , 1986, Nature.
[77] M. Mcdaniel,et al. A metabolite-regulated potassium channel in rat pancreatic B cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[78] O. Petersen,et al. Messenger-mediated control of potassium channels in secretory cells. , 1986, The Journal of experimental biology.
[79] C. Hales,et al. THE SULPHONYLUREA RECEPTOR MAY BE AN ATP-SENSITIVE POTASSIUM CHANNEL , 1985, The Lancet.
[80] N. Standen,et al. Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane , 1985, Nature.
[81] H. Morris,et al. Calcitonin gene-related peptide is a potent vasodilator , 1985, Nature.
[82] Stephen J. H. Ashcroft,et al. Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells , 1984, Nature.
[83] D. Cook,et al. Intracellular ATP directly blocks K+ channels in pancreatic B-cells , 1984, Nature.
[84] K. I. Williams,et al. Endothelial-dependent relaxant effects of vaso-active intestinal polypeptide and arachidonic acid in rat aortic strips. , 1984, Prostaglandins.
[85] A. Noma,et al. ATP-regulated K+ channels in cardiac muscle , 1983, Nature.
[86] C. Wollheim,et al. Specific receptors for sulfonylureas in brain and in a beta-cell tumor of the rat. , 1982, Biochemical pharmacology.
[87] T. Ono,et al. Glucoresponsive neurons in rat ventromedial hypothalamic tissue slices in vitro , 1982, Brain Research.
[88] C. Pace,et al. Somatostatin: Mechanism of Action in Pancreatic Islet β-Cells , 1981, Diabetes.
[89] V. Mutt,et al. Potent Peripheral and Splanchnic Vasodilator Peptide from Normal Gut , 1970, Nature.
[90] G. Edwards,et al. Potassium channel openers and vascular smooth muscle relaxation. , 1990, Pharmacology & therapeutics.
[91] T. Masaki,et al. Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats. , 1989, The Journal of pharmacology and experimental therapeutics.